Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validamycin A inhibitory and combination effects against Aspergillus flavus isolates
TCTR20180316003Not yet recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2018
- Countries
- 1
01
Overview
Open-label trial in Aspergillus flavus infection (3 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Inhibitory effects of validamycin A. Planned start Apr 2018; status: not yet recruiting.
02
Conditions
Aspergillus flavus infection
Beyond the preview
Go deeper on TCTR20180316003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180316003.